Walgreens Boots Alliance Inc (OQ:WBA)
Business Focus: Drug Retailers
| Sector: Consumer Non-Cyclicals | Industry: Drug Retailers |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 108 Wilmot Rd DEERFIELD IL 60015-5145 |
| Tel: | N/A |
| Website: | https://www.walgreensbootsalliance.com |
| IR: | See website |
| Key People | ||
| Stefano Pessina Executive Chairman of the Board | Tracey D. Brown Senior Vice President and President, Retail Products and Chief Customer Officer, Walgreen Co. | Timothy Charles Wentworth Chief Executive Officer, Director |
| Manmohan Lal Mahajan Global Chief Financial Officer, Executive Vice President | Elizabeth L. Burger Chief Human Resource Officer, Executive Vice President | Neal Sample Executive Vice President, Chief Information Officer |
| Kevin Ban Executive Vice President, Chief Medical Officer | Mary Langowski Executive Vice President, President, U.S. Healthcare | Lanesha T. Minnix Executive Vice President, Global Chief Legal Officer | Todd Heckman Senior Vice President, Chief Accounting Officer, Global Controller |
| Business Overview |
| Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey. |
| Financial Overview |
| For the six months ended 29 February 2024, Walgreens Boots Alliance Inc revenues increased 8% to $73.76B. Net loss applicable to common stockholders increased 98% to $5.98B. Revenues reflect Retail Pharmacy USA segment increase of 6% to $57.81B, US Healthcare segment increase of 57% to $4.11B, Comparable Store Sales (Growth- %), Phar increase from 4.9 to 10.9%, Retail Sales USA increase of 6% to $57.81B. |
| Employees: | 206,000 as of Aug 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $25,018M as of Feb 29, 2024 |
| Annual revenue (TTM): | $144,596M as of Feb 29, 2024 |
| EBITDA (TTM): | $4,403M as of Feb 29, 2024 |
| Net annual income (TTM): | -$6,037M as of Feb 29, 2024 |
| Free cash flow (TTM): | -$3,423M as of Feb 29, 2024 |
| Net Debt Last Fiscal Year: | $9,808M as of Feb 29, 2024 |
| Shares outstanding: | 862,713,366 as of Feb 29, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.